Internal Medicine

LB-102 Significantly Improves Disease Severity in Acute Schizophrenia, with John Kane, MD

by

LB-102: A New Horizon in Schizophrenia Treatment LB Pharmaceuticals has recently unveiled promising data from the NOVA phase 2 study at the 2025 Annual Congress of the Schizophrenia International Research Society. The study evaluated LB-102, a new benzamide antipsychotic, showing significant improvements in disease severity for patients with acute schizophrenia. With mean changes in Clinical … Read more

Herbicide poisoning causing multiple colonic perforations: case report | International Journal of Emergency Medicine

by

Understanding the Impact of 2,4-D Herbicide Poisoning 2,4-Dichlorophenoxyacetic acid (2,4-D) has been a widely used herbicide for its effectiveness against broadleaf weeds. However, its extensive use raises concerns about its toxicological effects on human health. This article delves into the key aspects of 2,4-D poisoning and explores future trends in managing and mitigating its impact. … Read more

Expanding Rapid Recovery Close to Home: Robotic-Assisted Joint Replacement Surgery

by

The Rise of Robotic-Assisted Joint Replacement Surgery As technology advances, robotic-assisted joint replacement surgery is becoming a game-changer in the healthcare industry. These cutting-edge procedures promise higher accuracy, less invasive processes, reduced recovery times, and lower complication risks. The AHN Orthopaedic Institute in western Pennsylvania is at the forefront of this movement, providing same-day surgery … Read more

Age-specific relationship between HIV and TB treatment outcomes in the West Region of Cameroon: a cross-sectional study | BMC Infectious Diseases

by

The Ongoing Challenge of TB and HIV Co-Infection Understanding the interconnectedness between tuberculosis (TB) and HIV remains pivotal in addressing the twin epidemics that continue to affect millions globally. Recent research highlights delays in TB treatment initiation, with studies from regions such as Southwestern Ethiopia underscoring the gap between diagnosis and treatment commencement. These delays … Read more

Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies

by

Emerging Trends in Wnt Pathway Inhibitors and Bone Health The Role of LGK974 in Bone Formation and Disease Management Recent explorations into the Wnt pathway have unveiled LGK974, a PORCN inhibitor, as a promising candidate in the therapeutic landscape of bone-related disorders like sclerosteosis. Studies on Sost-/- mice reveal its potential to modulate osteoblast activity, … Read more

Rivaroxaban Akin to Warfarin for Left Ventricular Thrombus After MI

by

The Promising Horizon of Anticoagulation: A Look at Rivaroxaban vs. Warfarin Anticoagulants have long played a pivotal role in managing conditions like myocardial infarction (MI) by preventing the formation of dangerous blood clots in the heart. The recent RIVAWAR trial sheds new light on rivaroxaban as a significant contender against warfarin, a standard treatment in … Read more

Intensive Medical Therapy Does Not Improve Outcomes in Women with INOCA

by

The WARRIOR Trial: A Landmark Study in Women’s Heart Health The recent conclusion of the WARRIOR trial has turned heads in the medical community, particularly among specialists treating ischemia without obstructive coronary artery disease (INOCA). Conducted as the largest randomized, pragmatic outcome trial for INOCA, the study has provided critical insights yet with a nuance … Read more

Prior Oral Anticoagulant Use May Influence Stroke, Bleeding Risk in AF

by

Exploring the Future of Anticoagulant Treatments for Atrial Fibrillation New Insights from OCEANIC-AF Study The recent findings from the Oral Factor 11a Inhibitor Asundexian as Novel Antithrombotic–Atrial Fibrillation (OCEANIC-AF) study opened up new possibilities in treating atrial fibrillation (AF) patients. Atrial fibrillation is a common heart condition led by irregular heartbeats, increasing the risk of … Read more

Novel Lipid Indicator Identifies Risk of Ischemic Heart Disease in T2D

by

Unlocking the Future of Lipid Management in Type 2 Diabetes A groundbreaking investigation has unveiled a potential game-changer in assessing ischemic heart disease (IHD) risks for individuals with type 2 diabetes (T2D): the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR). Led by Sikun Zhang of the Second Xiangya Hospital, this study highlights how … Read more

HCPLive 5 Stories in Under 5: Week of 03/16

by

Future Trends in Healthcare: Insights from Recent Developments Advancements in Migraine Treatment Protocols The recent update from the American College of Physicians (ACP) on adding a triptan to NSAIDs or acetaminophen for treating migraines marks a significant shift in acute migraine management. This combination therapy approach could influence new treatment algorithms across healthcare systems. Clinicians, … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]